Jasper Therapeutics (JSPR) Times Interest Earned (2020 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Times Interest Earned of -$31.93 for Q4 2025, up 62.87% year-over-year from -$19.61 in Q4 2024, and up 90.84% quarter-over-quarter from -$348.47 in Q3 2025.
Jasper Therapeutics (JSPR) Times Interest Earned (2020 - 2025) Analysis & Trends
Jasper Therapeutics' Times Interest Earned history runs 6 years deep, the most recent figure standing at -$31.93 for Q4 2025.
- In Q4 2025, Times Interest Earned rose 62.87% year-over-year to -$31.93; the TTM figure through Dec 2025 stood at -$62.09 (up 30.37% YoY), while the FY2025 annual figure was -$46.01, down 298.82% from the prior year.
- Times Interest Earned for Q4 2025 stood at -$31.93, up from -$348.47 in the prior quarter.
- The five-year high for Times Interest Earned was $78.97 in Q4 2021, with the low at -$348.47 in Q3 2025.
- The 5-year median for Times Interest Earned is -$25.59 (2021), against an average of -$50.67.
- The sharpest annual moves came in 2021 and 2025: Times Interest Earned jumped 321.34% in 2021, then plunged 6673.57% in 2025.
- Jasper Therapeutics' Times Interest Earned stood at $78.97 in 2021, then slumped by 120.58% to -$16.25 in 2022, then sank by 282.74% to -$62.19 in 2023, then plunged by 38.28% to -$86.0 in 2024, then surged by 62.87% to -$31.93 in 2025.
- Business Quant data shows JSPR's Times Interest Earned at -$31.93 in Q4 2025, -$348.47 in Q3 2025, and -$12.05 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 1.42 |
| 10 | Jasper Therapeutics | 20.08 Mn | 20.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -31.93 |
| Sep 30, 2025 | -348.47 |
| Jun 30, 2025 | -12.05 |
| Mar 31, 2025 | -159.14 |
| Dec 31, 2024 | -86.00 |
| Sep 30, 2024 | -5.14 |
| Jun 30, 2024 | -33.46 |
| Mar 31, 2024 | -21.26 |
| Dec 31, 2023 | -62.19 |
| Sep 30, 2023 | -5.75 |
| Jun 30, 2023 | -15.02 |
| Mar 31, 2023 | -50.53 |
| Dec 31, 2022 | -16.25 |
| Sep 30, 2022 | -17.10 |
| Jun 30, 2022 | -119.63 |
| Mar 31, 2022 | -2.57 |
| Dec 31, 2021 | 78.97 |
| Jun 30, 2021 | -25.59 |
| Mar 31, 2021 | -29.64 |
| Dec 31, 2020 | -35.68 |